21.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BEAM Giù?
Forum
Previsione
Beam Therapeutics Inc Borsa (BEAM) Ultime notizie
What is the dividend policy of Beam Therapeutics Inc. stockFree Market Volatility Navigation Tips - jammulinksnews.com
Is Beam Therapeutics Inc. stock overvalued or undervaluedAchieve rapid wealth accumulation with smart picks - jammulinksnews.com
Why is Beam Therapeutics Inc. stock attracting strong analyst attentionFree Consultation - jammulinksnews.com
How many analysts rate Beam Therapeutics Inc. as a “Buy”Exceptional growth trajectory - jammulinksnews.com
Published on: 2025-07-27 19:29:01 - jammulinksnews.com
Is Beam Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFree Real-Time Trading Opportunities - beatles.ru
Will Beam Therapeutics Inc. stock benefit from interest rate changesFree Market Dynamics Reports - jammulinksnews.com
What makes Beam Therapeutics Inc. stock attractive to long term investorsSuperior stock selection - jammulinksnews.com
What institutions are buying Beam Therapeutics Inc. stock nowOutperformance with explosive growth - jammulinksnews.com
What analysts say about Beam Therapeutics Inc. stockFree Popular Stock Recommendations - PrintWeekIndia
Trading (BEAM) With Integrated Risk Controls - news.stocktradersdaily.com
Can Beam Therapeutics Inc. stock recover from recent declineFree Smart Trading Workshop - jammulinksnews.com
Beam Therapeutics Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional
What drives Beam Therapeutics Inc. stock priceDynamic investment opportunities - jammulinksnews.com
Is Beam Therapeutics Inc. a good long term investmentRobust financial gains - jammulinksnews.com
Sickle Cell Disease Market Set to Grow Substantially Through 2034, DelveInsight Projects | Sanofi, CSL Behring, ITB-Med LLC, Novo Nordisk A/S, Fortrea, Inc., Novartis, Afimmune, Pfizer, ADDMEDICA SASA - The Globe and Mail
Beam Therapeutics (BEAM) Announces Acquisition of an Early-Stage Life Sciences Company - MSN
12 Oversold NASDAQ Stocks to Buy Now - Insider Monkey
(BEAM) Trading Report - news.stocktradersdaily.com
Beam Therapeutics (BEAM) Surges 5.7%: Is This an Indication of Further Gains? - MSN
H.C. Wainwright Reiterates a Buy Rating on Beam Therapeutics (BEAM) With an $80 PT - MSN
Cathie Wood’s ARK ETF bolsters Beam stock, sheds Roblox - Investing.com
Beam Therapeutics: A Base Editing Breakthrough With Catalysts to Ignite Value - AInvest
Beam Therapeutics’ BEAM-101 Shows Promising Results in Sickle Cell Disease Trial - MSN
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):